{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T08:20:23Z","timestamp":1771748423049,"version":"3.50.1"},"reference-count":105,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/bor.0b013e32835689b9","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T08:38:23Z","timestamp":1343205503000},"page":"506-514","source":"Crossref","is-referenced-by-count":5,"title":["Monogenic causes of inflammatory disease in rheumatology"],"prefix":"10.1097","volume":"24","author":[{"given":"James W.","family":"Verbsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","article-title":"Familial Mediterranean fever. a survey of 470 cases and review of the literature.","volume":"43","author":"Sohar","year":"1967","journal-title":"Am J Med"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/1529-0131(200106)44:6<1416::AID-ART236>3.0.CO;2-6","article-title":"The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease.","volume":"44","author":"Brik","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-3476(05)80667-5","article-title":"Long-term colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis).","volume":"116","author":"Majeed","year":"1990","journal-title":"J Pediatr"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00296-001-0168-5","article-title":"Arthritis in children with familial Mediterranean fever.","volume":"21","author":"Ince","year":"2002","journal-title":"Rheumatol Int"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3476(78)81107-X","article-title":"Long-term colchicine therapy of familial Mediterranean fever.","volume":"93","author":"Lehman","year":"1978","journal-title":"J Pediatr"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/art.1780340806","article-title":"Long-term colchicine treatment in children with familial Mediterranean fever.","volume":"34","author":"Zemer","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/art.1780371215","article-title":"Colchicine treatment of AA amyloidosis of familial Mediterranean fever. an analysis of factors affecting outcome.","volume":"37","author":"Livneh","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R8-10-20210128","first-page":"509","article-title":"Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.","volume":"21","author":"Duzova","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3899\/jrheum.100718","article-title":"Antiinterleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.","volume":"38","author":"Ozen","year":"2011","journal-title":"J Rheumatol"},{"key":"R10-10-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semarthrit.2010.11.003","article-title":"Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature.","volume":"41","author":"Meinzer","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"R11-10-20210128","first-page":"797","article-title":"The International FMF Consortium.","volume":"90","year":"1997","journal-title":"Cell"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1073\/pnas.0602081103","article-title":"The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production.","volume":"103","author":"Chae","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"39320","DOI":"10.1074\/jbc.M104730200","article-title":"Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis.","volume":"276","author":"Richards","year":"2001","journal-title":"J Biol Chem"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2008-01-134932","article-title":"The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment.","volume":"112","author":"Chae","year":"2008","journal-title":"Blood"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrrheum.2010.181","article-title":"Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.","volume":"7","author":"Ben-Zvi","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/03009740801998788","article-title":"Molecular analysis of MEFV gene mutations among Palestinian patients with Behcets disease.","volume":"37","author":"Ayesh","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/03009742.2011.562532","article-title":"Common MEFV mutations in Iranian Azeri Turkish patients with Behcets disease.","volume":"40","author":"Esmaeili","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"41783","DOI":"10.1155\/MI\/2006\/41783","article-title":"Genetic analysis of MEFV gene pyrin domain in patients with Behcets disease.","volume":"2006","author":"Dursun","year":"2006","journal-title":"Mediators Inflamm"},{"key":"R20-10-20210128","first-page":"S24","article-title":"MEFV, TNFRSF1A and CARD15 mutation analysis in Behcets disease.","volume":"29","author":"Baruch","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(85)80394-2","article-title":"Familial granulomatous arthritis, iritis, and rash.","volume":"107","author":"Blau","year":"1985","journal-title":"J Pediatr"},{"key":"R23-10-20210128","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-3476(05)81080-7","article-title":"Autosomal dominant granulomatous arthritis, uveitis, skin rash, and synovial cysts.","volume":"117","author":"Pastores","year":"1990","journal-title":"J Pediatr"},{"key":"R24-10-20210128","first-page":"842","article-title":"Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis.","volume":"147","author":"Raphael","year":"1993","journal-title":"Am J Dis Child"},{"key":"R25-10-20210128","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0002-9343(85)90286-4","article-title":"Familial granulomatous synovitis, uveitis, and cranial neuropathies.","volume":"78","author":"Jabs","year":"1985","journal-title":"Am J Med"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.24134","article-title":"Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.","volume":"60","author":"Okafuji","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R27-10-20210128","first-page":"396","article-title":"Liver involvement in familial granulomatous arthritis (Blau syndrome).","volume":"23","author":"Saini","year":"1996","journal-title":"J Rheumatol"},{"key":"R28-10-20210128","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.autrev.2008.07.034","article-title":"Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review.","volume":"8","author":"Punzi","year":"2009","journal-title":"Autoimmun Rev"},{"key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1600-0463.2006.apm_522.x","article-title":"Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation.","volume":"114","author":"Milman","year":"2006","journal-title":"APMIS"},{"key":"R30-10-20210128","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/art.22966","article-title":"NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort.","volume":"56","author":"Arostegui","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R31-10-20210128","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/art.25035","article-title":"Thalidomide dramatically improves the symptoms of early-onset sarcoidosisBlau syndrome: its possible action and mechanism.","volume":"62","author":"Yasui","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R32-10-20210128","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/art.24222","article-title":"The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity.","volume":"60","author":"Martin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R33-10-20210128","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","article-title":"Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.","volume":"105","author":"Kanazawa","year":"2005","journal-title":"Blood"},{"key":"R34-10-20210128","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohns disease.","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"R35-10-20210128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohns disease.","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"R36-10-20210128","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.0530276100","article-title":"Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.","volume":"100","author":"Chamaillard","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R37-10-20210128","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.1104911","article-title":"Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.","volume":"307","author":"Kobayashi","year":"2005","journal-title":"Science"},{"key":"R38-10-20210128","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","article-title":"Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder.","volume":"11","author":"Wise","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R39-10-20210128","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1086\/302866","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q.","volume":"66","author":"Yeon","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R40-10-20210128","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","article-title":"A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome.","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"R41-10-20210128","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/1529-0131(200009)43:9<2041::AID-ANR15>3.0.CO;2-G","article-title":"Localization of a gene for familial recurrent arthritis.","volume":"43","author":"Wise","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R42-10-20210128","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/art.34332","article-title":"Genotype, phenotype, and clinical course in five patients with pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome.","volume":"64","author":"Demidowich","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R43-10-20210128","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","article-title":"Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.","volume":"161","author":"Brenner","year":"2009","journal-title":"Br J Dermatol"},{"key":"R44-10-20210128","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/keh479","article-title":"Anakinra for flares of pyogenic arthritis in PAPA syndrome.","volume":"44","author":"Dierselhuis","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R45-10-20210128","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/RHU.0b013e3181e969b9","article-title":"Clinical efficacy of etanercept for treatment of PAPA syndrome.","volume":"16","author":"Tofteland","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"R46-10-20210128","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1525-1470.2005.22320.x","article-title":"Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome.","volume":"22","author":"Stichweh","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"R47-10-20210128","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1083\/jcb.138.4.845","article-title":"PSTPIP: a tyrosine phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase.","volume":"138","author":"Spencer","year":"1997","journal-title":"J Cell Biol"},{"key":"R48-10-20210128","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2007.08.029","article-title":"Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants.","volume":"28","author":"Yu","year":"2007","journal-title":"Mol Cell"},{"key":"R49-10-20210128","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.2135380100","article-title":"Pyrin binds the PSTPIP1CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway.","volume":"100","author":"Shoham","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R50-10-20210128","doi-asserted-by":"crossref","first-page":"14914","DOI":"10.1073\/pnas.1106015108","article-title":"Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome.","volume":"108","author":"Arima","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R51-10-20210128","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ajhg.2010.10.031","article-title":"PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome.","volume":"87","author":"Agarwal","year":"2010","journal-title":"Am J Hum Genet"},{"key":"R52-10-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2009.04.046","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome.","volume":"62","author":"Torrelo","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R53-10-20210128","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.33368","article-title":"Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity.","volume":"64","author":"Liu","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R54-10-20210128","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2010.07.036","article-title":"Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.","volume":"142","author":"Seifert","year":"2010","journal-title":"Cell"},{"key":"R55-10-20210128","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/eji.201040620","article-title":"Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice.","volume":"40","author":"Moebius","year":"2010","journal-title":"Eur J Immunol"},{"key":"R56-10-20210128","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s004310100799","article-title":"The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia: report of a new family and a review.","volume":"160","author":"Majeed","year":"2001","journal-title":"Eur J Pediatr"},{"key":"R57-10-20210128","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1067\/mpd.2000.107613","article-title":"On mice and men: an autosomal recessive syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia.","volume":"137","author":"Majeed","year":"2000","journal-title":"J Pediatr"},{"key":"R58-10-20210128","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11926-012-0239-5","article-title":"Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis.","volume":"14","author":"Ferguson","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"R59-10-20210128","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/jmg.2005.030759","article-title":"Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome).","volume":"42","author":"Ferguson","year":"2005","journal-title":"J Med Genet"},{"key":"R61-10-20210128","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N Engl J Med"},{"key":"R62-10-20210128","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","article-title":"An autoinflammatory disease due to homozygous deletion of the IL1RN locus.","volume":"360","author":"Reddy","year":"2009","journal-title":"N Engl J Med"},{"key":"R63-10-20210128","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/340786","article-title":"New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes.","volume":"70","author":"Dode","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R64-10-20210128","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1067\/mai.2001.118790","article-title":"Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever.","volume":"108","author":"Hoffman","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"R65-10-20210128","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1002\/art.20633","article-title":"Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1PYPAF1NALP3 gene.","volume":"50","author":"Arostegui","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R66-10-20210128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.iac.2004.01.001","article-title":"The spectrum of acquired and familial cold-induced urticariaurticaria-like syndromes.","volume":"24","author":"Wanderer","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"R67-10-20210128","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0560.2010.01638.x","article-title":"Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement.","volume":"38","author":"Kolivras","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R68-10-20210128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-3476(81)80961-4","article-title":"Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation.","volume":"99","author":"Prieur","year":"1981","journal-title":"J Pediatr"},{"key":"R69-10-20210128","first-page":"103","article-title":"A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy.","volume":"19","author":"Prieur","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"R70-10-20210128","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/341357","article-title":"Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes.","volume":"71","author":"Feldmann","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R71-10-20210128","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/art.10688","article-title":"De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.","volume":"46","author":"Aksentijevich","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R72-10-20210128","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","article-title":"Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.","volume":"50","author":"Hawkins","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R73-10-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome.","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat Genet"},{"key":"R74-10-20210128","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/art.10509","article-title":"Association of mutations in the NALP3CIAS1PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis.","volume":"46","author":"Aganna","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R75-10-20210128","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2003-07-2531","article-title":"Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCANOMID, MWS, and FCU.","volume":"103","author":"Neven","year":"2004","journal-title":"Blood"},{"key":"R76-10-20210128","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1002\/art.30512","article-title":"High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study.","volume":"63","author":"Tanaka","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R77-10-20210128","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.25057","article-title":"Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory diseasechronic infantile neurologic, cutaneous, articular syndrome.","volume":"62","author":"Neven","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R78-10-20210128","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","article-title":"A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome.","volume":"58","author":"Goldbach-Mansky","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R79-10-20210128","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.20953","article-title":"Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease.","volume":"52","author":"Lovell","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R80-10-20210128","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","article-title":"Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist.","volume":"364","author":"Hoffman","year":"2004","journal-title":"Lancet"},{"key":"R81-10-20210128","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20082481","article-title":"In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes.","volume":"206","author":"Lachmann","year":"2009","journal-title":"J Exp Med"},{"key":"R82-10-20210128","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/art.34409","article-title":"Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease (NOMID) treated with anakinra.","volume":"64","author":"Sibley","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R83-10-20210128","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/art.30170","article-title":"Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation.","volume":"63","author":"Borghini","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R84-10-20210128","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1073\/pnas.0708616105","article-title":"Mutations in NALP12 cause hereditary periodic fever syndromes.","volume":"105","author":"Jeru","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R85-10-20210128","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/art.30378","article-title":"Role of interleukin-1beta in NLRP12-associated autoinflammatory disorders and resistance to antiinterleukin-1 therapy.","volume":"63","author":"Jeru","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R86-10-20210128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"R87-10-20210128","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RNIL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R88-10-20210128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"R89-10-20210128","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archderm.136.12.1487","article-title":"Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations.","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"key":"R90-10-20210128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","article-title":"The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.","volume":"81","author":"Hull","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R91-10-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/keg070","article-title":"Prospective study of antitumour necrosis factor receptor superfamily 1B fusion protein, and case study of antitumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients.","volume":"42","author":"Drewe","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R92-10-20210128","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/art.23475","article-title":"Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome.","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R93-10-20210128","first-page":"357","article-title":"Dramatic improvement following interleukin 1beta blockade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy.","volume":"35","author":"Sacre","year":"2008","journal-title":"J Rheumatol"},{"key":"R94-10-20210128","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.30215","article-title":"Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the antiinterleukin-6 receptor monoclonal antibody tocilizumab.","volume":"63","author":"Vaitla","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R95-10-20210128","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/art.11215","article-title":"Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes.","volume":"48","author":"Aganna","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R96-10-20210128","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1182\/blood-2005-11-006783","article-title":"Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS).","volume":"108","author":"Lobito","year":"2006","journal-title":"Blood"},{"key":"R97-10-20210128","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1073\/pnas.0914118107","article-title":"Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.","volume":"107","author":"Simon","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R98-10-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.","volume":"87","author":"Van der Hilst","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"R99-10-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archderm.1994.01690010063008","article-title":"Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group.","volume":"130","author":"Drenth","year":"1994","journal-title":"Arch Dermatol"},{"key":"R100-10-20210128","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1136\/ard.2011.149922","article-title":"On-demand anakinra treatment is effective in mevalonate kinase deficiency.","volume":"70","author":"Bodar","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R101-10-20210128","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0002-9343(02)01429-8","article-title":"A founder effect in the hyperimmunoglobulinemia D and periodic fever syndrome.","volume":"114","author":"Simon","year":"2003","journal-title":"Am J Med"},{"key":"R102-10-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/9691","article-title":"Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome.","volume":"22","author":"Houten","year":"1999","journal-title":"Nat Genet"},{"key":"R103-10-20210128","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat Genet"},{"key":"R104-10-20210128","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.10550","article-title":"Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.","volume":"46","author":"Frenkel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R105-10-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","article-title":"Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.","volume":"13","author":"Ravelli","year":"2012","journal-title":"Genes Immun"},{"key":"R106-10-20210128","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","article-title":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms.","volume":"58","author":"Zhang","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R107-10-20210128","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/art.23199","article-title":"Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis.","volume":"58","author":"Hazen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R108-10-20210128","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","article-title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.","volume":"49","author":"Vastert","year":"2010","journal-title":"Rheumatology (Oxford)"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e32835689b9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:04:03Z","timestamp":1620947043000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201209000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32835689b9","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}